Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to R01:11

Introduction to R

5.0K
R is a powerful software environment for statistical computing and graphics. Originating as an implementation of the S language, developed at Bell Laboratories, R has evolved into a robust, open-source statistical software favored by statisticians and data scientists worldwide. Its comprehensive suite includes data manipulation, calculation, and graphical display capabilities, making it versatile for data analysis and visualization. Its programming language is at the core of R's...
5.0K
Introduction to Statistics01:17

Introduction to Statistics

63.8K
The science of statistics involves collecting, analyzing, interpreting, and presenting data. The method of collecting, organizing, and summarizing data is called descriptive statistics. The systematic method of drawing inferences from the sample data and predicting unknown characteristics of a population is called inferential statistics.
In statistics, the collection of individuals or objects under study is called population. The idea of sampling is to select a portion of the larger population...
63.8K
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

4.0K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
4.0K
Introduction to Actin01:26

Introduction to Actin

6.6K
Actin is a highly conserved cytoskeletal protein found abundantly in eukaryotic cells. It constitutes 10% weight of the total cellular protein in muscle cells, while in non-muscle cells, it is lower and makes up around 1–5 percent of the total cell protein. Actin found in the unicellular amoebae and complex multicellular animals is around 80% similar, demonstrating their conservation over a billion years of evolution.  Actin coding genes are conserved within species and across...
6.6K
Introduction to One-to-one Functions01:23

Introduction to One-to-one Functions

204
A one-to-one function is a mathematical function in which each element of the domain maps to a distinct and unique element in the range. This property ensures that no two different inputs result in the same output, formally expressed as f (x1) ≠ f (x2) whenever x1 ≠ x2. The graphical criterion for identifying such functions is the Horizontal Line Test, which indicates that a function is one-to-one if and only if no horizontal line intersects its graph at more than one point.A...
204
Introduction to Limits01:30

Introduction to Limits

243
A limit describes the value a function approaches as its input moves closer to a particular point. Even when a function is undefined at a specific value, limits allow us to analyze its behavior near that point. This concept is fundamental in calculus and essential for understanding continuity, derivatives, and integrals.Mathematically, a function f(x) has a limit L at x = a if its values L approach x as x gets arbitrarily close to a. This is written as:This notation expresses that the function...
243

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tracking economic change over a decade: an analysis of Austria's industry-sponsored clinical trial landscape and implications for policy.

Journal of medical economics·2026
Same author

Cost-effectiveness of vasopressin in the treatment of septic shock: insights from a European societal perspective.

Journal of medical economics·2026
Same author

Cost-effectiveness of the Floodlight<sup>®</sup> MS app in Austria. Unlocking the mystery of costs and outcomes of a digital health application for patients with multiple sclerosis.

Digital health·2025
Same author

Cost-utility analysis of ropeginterferon alfa-2b to manage low-risk patients with polycythemia vera as compared to phlebotomy only in the Austrian healthcare system.

Annals of hematology·2025
Same author

Cost-effectiveness of teduglutide in adult patients with short bowel syndrome - a European socioeconomic perspective.

The American journal of clinical nutrition·2024
Same author

A budget impact analysis of a powered hybrid mattress to prevent pressure ulcers in the Austrian inpatient setting: An original research.

Health science reports·2024

Related Experiment Video

Updated: Feb 1, 2026

A Microfluidic Chip for ICPMS Sample Introduction
11:16

A Microfluidic Chip for ICPMS Sample Introduction

Published on: March 5, 2015

11.8K

Introduction and Overview.

Evelyn Walter1

  • 1Institute for Pharmaeconomic Research, Vienna, Austria. ew@ipf-ac.at.

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|December 14, 2018
PubMed
Summary

Rapid advancements in oncology treatments necessitate updated economic and regulatory frameworks. This book explores essential modifications to health economics tools for cancer care, emphasizing value and patient access.

Area of Science:

  • Oncology
  • Health Economics
  • Regulatory Science

Background:

  • Rapid developments in cancer treatments are outpacing traditional health economic and regulatory approaches.
  • Existing health economic evaluation, health technology assessment (HTA), and pricing techniques require adaptation for oncology.

Purpose of the Study:

  • To outline necessary changes in economic and regulatory conditions driven by advancements in oncology.
  • To explore how traditional health economics tools must evolve to meet the unique challenges of cancer care.

Main Methods:

  • The book contributes insights into modifying established health economic tools.
  • It examines decision rules for cancer treatments, including willingness to pay, cost-effectiveness thresholds, equity, and end-of-life criteria.
Keywords:
Cancer incidenceOncology conePrices of cancer medication

More Related Videos

Author Spotlight: Balancing Speed, Cost, and Accuracy in Neutrophil Function Assessment with NeutroFun Screen Protocol
12:27

Author Spotlight: Balancing Speed, Cost, and Accuracy in Neutrophil Function Assessment with NeutroFun Screen Protocol

Published on: February 9, 2024

3.8K
An Introduction to Worm Lab: from Culturing Worms to Mutagenesis
10:44

An Introduction to Worm Lab: from Culturing Worms to Mutagenesis

Published on: January 11, 2011

35.7K

Related Experiment Videos

Last Updated: Feb 1, 2026

A Microfluidic Chip for ICPMS Sample Introduction
11:16

A Microfluidic Chip for ICPMS Sample Introduction

Published on: March 5, 2015

11.8K
Author Spotlight: Balancing Speed, Cost, and Accuracy in Neutrophil Function Assessment with NeutroFun Screen Protocol
12:27

Author Spotlight: Balancing Speed, Cost, and Accuracy in Neutrophil Function Assessment with NeutroFun Screen Protocol

Published on: February 9, 2024

3.8K
An Introduction to Worm Lab: from Culturing Worms to Mutagenesis
10:44

An Introduction to Worm Lab: from Culturing Worms to Mutagenesis

Published on: January 11, 2011

35.7K

Main Results:

  • Traditional health economics methods need significant alteration for oncology applications.
  • The application of economic principles in cancer care differs substantially from other therapeutic areas.

Conclusions:

  • A modified concept of oncology economics is likely necessary.
  • Adapting economic and regulatory frameworks is crucial for ensuring optimal patient access to innovative cancer treatments.